<DOC>
	<DOC>NCT01037036</DOC>
	<brief_summary>The objective of this study is to investigate how the intraocular pressure (IOP)-lowering effect of the L-PPDS is altered by adjunctive Xalatan therapy.</brief_summary>
	<brief_title>A Study of the L-PPDS With Adjunctive XalatanÂ® Eye Drops in Subjects With OH or OAG</brief_title>
	<detailed_description />
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Glaucoma</mesh_term>
	<mesh_term>Glaucoma, Open-Angle</mesh_term>
	<mesh_term>Ocular Hypertension</mesh_term>
	<mesh_term>Latanoprost</mesh_term>
	<mesh_term>Ophthalmic Solutions</mesh_term>
	<mesh_term>Tetrahydrozoline</mesh_term>
	<criteria>Over 18 years Diagnosed with bilateral OpenAngle Glaucoma or Ocular Hypertension Currently on prostaglandin therapy Uncontrolled medical conditions Subjects who wear contact lenses Subjects requiring chronic topical artificial tears, lubricants, and /or requiring any other chronic topical medications</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2013</verification_date>
	<keyword>Ocular Hypertension</keyword>
	<keyword>Open-Angle Glaucoma</keyword>
	<keyword>Xalatan</keyword>
	<keyword>IOP</keyword>
</DOC>